ABCL vs JPM Stock Comparison

JPM currently leads ABCL in this stock comparison, with AIQ scores of 65 vs 64. The clearest difference is risk resilience, while ABCL has the stronger value profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 1 points
ABCL
Healthcare
vs
JPM
Financial Services
ABCL
AbCellera Biologics Inc.
Price
$11.49
Day move
-1.12%
AIQ Score
64/100
Best edge
Value
Sector
Healthcare
JPM
JPMorgan Chase & Co.
Leads
Price
$346
Day move
+0.98%
AIQ Score
65/100
Best edge
Risk Resilience
Sector
Financial Services

What is the main difference between ABCL and JPM?

JPM leads the current stock comparison as JPMorgan Chase & Co., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

AbCellera Biologics Inc. vs JPMorgan Chase & Co.

Data as of Nov 15, 2026· market close· Cross-sector · Healthcare vs Financial Services· Coverage 65/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 2/10

JPM leads

JPM leads by 1 AIQ points, primarily on Risk Resilience and Quality. Wall Street currently favors ABCL on target upside.

Fragile: 1 of 6 evidence groups support JPM, and its current signal state is conflicted.

Evidence agreement: 1 of 6Comparison trend: Stable
ABCL

AbCellera Biologics Inc.

AIQ Score
64/100
AIQ Edge Score
7/10
JPM

JPMorgan Chase & Co.

Leads
AIQ Score
65/100
AIQ Edge Score
8/10

The Algovestiq AIQ Score currently favors JPM over ABCL, 65 versus 64 as of Nov 15, 2026. JPM's advantage is driven primarily by stronger risk resilience and quality, while ABCL holds the stronger value profile. JPM also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors ABCL. 1 of 6 covered evidence groups favor JPM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 1 points. JPM lead: Stable — the AIQ differential has held near 1 points over 30 sessions.

Compare AbCellera Biologics Inc. and JPMorgan Chase & Co. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Total return with distributions reinvested, from daily closes.

ABCL
-22.5%
JPM
+138.4%

Total return comparison

Growth of $10,000, distributions reinvested

ABCL $7,753 · JPM $23,841

Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.

Compare ABCL and JPM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

ABCL advantage
0
JPM advantage
  • Risk Resilience34 vs 87
    JPM +53
  • Value47 vs 10
    ABCL +37
  • Quality61 vs 86
    JPM +25
  • Momentum89 vs 70
    ABCL +19

1 of 6 evidence groups favor JPM. JPM’s edge is concentrated in risk resilience and quality; ABCL keeps a meaningful value edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

ABCL+1 AIQ

Largest factor move: Momentum +2

No signal started or stopped since the prior session; its 4 active signals are unchanged.

JPM0 AIQ

Largest factor move: Momentum +1, not enough on its own to move the overall score.

New signals

  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon

JPM's lead narrowed by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — ABCL and JPM both carry a full feed there.

The central trade-off

JPM (JPMorgan Chase & Co.): the stronger current systematic profile, led by risk resilience and quality.

ABCL (AbCellera Biologics Inc.): the counter-case, on value, momentum, fundamentals — but at materially higher volatility, 88.8% against 27.4%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

JPM

JPM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

ABCL

ABCL on combined revenue and EPS growth.

Value

ABCL

ABCL on the peer-relative Value factor, by 37 points.

Momentum

ABCL

ABCL on the Momentum factor, by 19 points.

Lower downside

JPM

JPM on Risk Resilience, by 53 points.

Analyst upside

ABCL

ABCL on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors JPM, analyst targets favor ABCL. That disagreement is the most useful thing on this page.

MeasureABCLJPMNote
Implied upside to target+50.9%+7.8%ABCL has more room
Target dispersion+46.2%+30.3%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1326Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

1 of 6 covered evidence groups favor JPM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven64 vs 65
FundamentalsABCLon balancerevenue growth 162.7% vs -7.6%; EPS growth 27.8% vs -27.6%; TTM ROE -3.8% vs 4.1%; gross margin 75.6% vs 63.2%; operating margin -298% vs 28.2% — ABCL takes 3 of 5 decided legs, not all of them
ValuationABCLValue 47 vs 10
TechnicalsABCLPrice vs 50-day -6.9% vs 1.7%; vs 200-day 58.8% vs 6.6%
Risk ResilienceJPMRisk Resilience 34 vs 87
Analyst expectationsABCLTarget upside 50.9% vs 7.8%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of ABCL and JPM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 1 points. (argues the conclusion is provisional)
  • Only 1 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has been steady session to session. (supports the conclusion holding)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on JPM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

JPM lead: Stable — the AIQ differential has held near 1 points over 30 sessions.

May 27ABCL leads above the line · JPM leads belowNov 13
Today
JPM +1
64 vs 65
7 sessions ago
JPM +2
62 vs 64
30 sessions ago
JPM +1
62 vs 63
90 sessions ago
Level
64 vs 64

The lead changed hands 2 times in this window, most recently on Nov 11 when JPM moved ahead of ABCL.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

ABCLConflicted

1 bullish / 2 bearish / 1 neutral, conflicted

Only ABCL

  • ATR Expansion - Breakout Mode — neutral, volatility, short horizon (8.22%)
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • MACD Histogram Expanding Bearish — bearish, momentum, short horizon
JPMConflicted

6 bullish / 1 bearish / 1 neutral, conflicted

Only JPM

  • Bollinger Band Squeeze — neutral, volatility, short horizon (5.9%)
  • Drawdown Recovery Signal — bullish, risk_regime, long horizon (-9.0%)
  • EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.65x)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon
  • Uptrend Structure Active — bullish, trend, long horizon

Both carry 1 more signal that do not separate them: Golden Cross Active.

JPM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

ABCLDivergence

Price is down while the AIQ Score moved up 1 points over the same session — price and model disagree (price -1.12%, AIQ +1 points).

JPMNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.98%, AIQ 0 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1ABCL closes the Risk Resilience gap — currently 53 points behind, the largest single contributor to JPM's edge.
  2. 2ABCL's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it.
  3. 3JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

ABCL leads on balance
MetricABCLJPM
Revenue growth (YoY)162.7%-7.6%
EPS growth (YoY)27.8%-27.6%
Gross margin75.6%63.2%
Operating margin-298%28.2%
Return on equity (TTM)-3.8%4.1%
Debt to equity0.133.32

Performance

ABCL leads 4 of 6 windows
MetricABCLJPM
1 week (5 sessions)-3.3%3.5%
1 month (20 sessions)-2.6%1.9%
3 months (63 sessions)2.6%-4.1%
6 months (126 sessions)180.9%16.2%
Year to date236%7.4%
1 year (252 sessions)189.4%8%

Technicals

ABCL has the stronger structure
MetricABCLJPM
RSI (14)45.256.1
ADX (14)11.918
Price vs 50-day-6.9%1.7%
Price vs 200-day58.8%6.6%
Volatility (1M, annualized)88.8%27.4%

Risk

JPM is the more resilient
MetricABCLJPM
Beta2.420.78
Sharpe ratio1.730.44
Sortino ratio3.020.61
Max drawdown-40.1%-15.5%
Current drawdown-22.5%-5.2%
Annualized volatility85.3%22.7%
Value at risk (95%)-7.1%-2.4%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, ABCL or JPM?

On the Algovestiq AIQ Score, JPM is the stronger of the two as of Nov 15, 2026, scoring 65 against ABCL's 64. The edge comes from risk resilience and quality. ABCL is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is ABCL or JPM the better buy right now?

JPM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 1 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 1 points. Treat the lead as provisional.

Why does the AIQ Score favor JPM over ABCL?

The composite weights Quality, Value, Momentum and Risk Resilience. JPM leads Risk Resilience by 53 points; ABCL leads Value by 37 points; JPM leads Quality by 25 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, ABCL or JPM?

Analyst price targets imply +50.9% upside for ABCL and +7.8% for JPM, so the Street currently favors ABCL. That points the opposite way to the AIQ Score, which favors JPM. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, ABCL or JPM?

ABCL is the better-valued of the two on the peer-relative Value factor. ABCL on the peer-relative Value factor, by 37 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, ABCL or JPM?

ABCL on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, ABCL or JPM?

ABCL on the Momentum factor, by 19 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, ABCL or JPM?

JPM is the more resilient of the two, so the other name carries the higher downside risk. JPM on Risk Resilience, by 53 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is ABCL more profitable than JPM?

The profitability evidence is mixed: gross margin 75.6% vs 63.2%; operating margin -298% vs 28.2%; ttm roe -3.8% vs 4.1%. ABCL leads on one measure and JPM on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.

Is JPM's lead over ABCL getting stronger or weaker?

JPM lead: Stable — the AIQ differential has held near 1 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-11-11, when JPM moved ahead of ABCL.

What would change the ABCL vs JPM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: ABCL closes the Risk Resilience gap — currently 53 points behind, the largest single contributor to JPM's edge; ABCL's Beta Spike Warning resolves — a bearish risk_regime rule currently active against it; JPM's conflicting signal state resolves bearish — it currently carries 6 bullish and 1 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about ABCL and JPM?

ABCL: 1 bullish / 2 bearish / 1 neutral, conflicted. JPM: 6 bullish / 1 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on ABCL is Golden Cross Active (bullish, long horizon). On JPM it is Golden Cross Active (bullish, long horizon).

Compare ABCL and JPM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.